[Chronic kidney disease (CKD) and bone. CKD-MBD managements and view in the future].
The concept of CKD-MBD infiltrated all over the world in a short term. However, the guideline vary by each country because evidences and management goals are different. So, it is not necessarily maintained under the present situation. And it is expected the internationalization of the guideline and more scientific clarifications of management goals. Unfortunately, the JSDT guideline is not necessarily appreciated due to its evidence level. Thus, it is needed the examination of the validity of target values of management, the advancement of the evidence level, and development into non-dialyzed patients. In addition, the management and treatment method of CKD-MBD is developing though some new medicines were developed. It is hoped that the advancement of this field in the future to lead to the improvement of prognosis of CKD patients.